Correlation Between Terns Pharmaceuticals and AnaptysBio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and AnaptysBio, you can compare the effects of market volatilities on Terns Pharmaceuticals and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and AnaptysBio.

Diversification Opportunities for Terns Pharmaceuticals and AnaptysBio

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Terns and AnaptysBio is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and AnaptysBio go up and down completely randomly.

Pair Corralation between Terns Pharmaceuticals and AnaptysBio

Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 0.45 times more return on investment than AnaptysBio. However, Terns Pharmaceuticals is 2.22 times less risky than AnaptysBio. It trades about -0.11 of its potential returns per unit of risk. AnaptysBio is currently generating about -0.07 per unit of risk. If you would invest  651.00  in Terns Pharmaceuticals on August 29, 2024 and sell it today you would lose (63.00) from holding Terns Pharmaceuticals or give up 9.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Terns Pharmaceuticals  vs.  AnaptysBio

 Performance 
       Timeline  
Terns Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Terns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
AnaptysBio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AnaptysBio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Terns Pharmaceuticals and AnaptysBio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Terns Pharmaceuticals and AnaptysBio

The main advantage of trading using opposite Terns Pharmaceuticals and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.
The idea behind Terns Pharmaceuticals and AnaptysBio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios